PJ Harvey to perform in Denmark again this autumn

Tickets for her concert go on sale on Thursday

After her mesmerising performance at the Roskilde Festival, the British singer and musician PJ Harvey has announced she will return to Denmark this autumn to give another concert.

Harvey will perform at Falconer Salen in Frederiksberg on October 10.

Tickets will go on sale on July 14 at 10:00 at billetlugen.dk and will cost between 530 to 630 kroner.

READ MORE: Roskilde Festival: Wonderful, wild and just a little bit wet

New album
Polly Jean Harvey started her musical career in 1988 as a vocalist, guitarist, and saxophone player.

In 1991, she formed PJ Harvey Trio and began her professional career.

In April this year, the feminist rock singer released her ninth album ‘The hope six demolition project’, which she will promote in Denmark as part of her international tour.





  • How internationals can benefit from joining trade unions

    How internationals can benefit from joining trade unions

    Being part of a trade union is a long-established norm for Danes. But many internationals do not join unions – instead enduring workers’ rights violations. Find out how joining a union could benefit you, and how to go about it.

  • Internationals in Denmark rarely join a trade union

    Internationals in Denmark rarely join a trade union

    Internationals are overrepresented in the lowest-paid fields of agriculture, transport, cleaning, hotels and restaurants, and construction – industries that classically lack collective agreements. A new analysis from the Workers’ Union’s Business Council suggests that internationals rarely join trade unions – but if they did, it would generate better industry standards.

  • Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    Novo Nordisk overtakes LEGO as the most desirable future workplace amongst university students

    The numbers are especially striking amongst the 3,477 business and economics students polled, of whom 31 percent elected Novo Nordisk as their favorite, compared with 20 percent last year.